All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

312

Reset

312 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • JMBI-001Phase 21 trial

    Chengdu Anticancer Bioscience, Ltd. · Advance Solid Tumors, Lymphoma, Non-Hodgkin

  • JNJ-90014496Phase 21 trial

    Johnson & Johnson (Janssen) · Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

  • KITE-363Phase 21 trial

    Gilead Sciences · Relapsed and/or Refractory B-cell Lymphoma

  • lacutamabIPH4102Phase 21 trial

    Innate Pharma · Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome

  • LB-100Phase 21 trial

    Lixte Biotechnology Holdings, Inc. · Myelodysplastic Syndromes

  • LBL-034Phase 21 trial

    Nanjing Leads Biolabs Co.,Ltd · Relapsed/Refractory Multiple Myeloma

  • Liso-celPhase 21 trial

    Bristol Myers Squibb · Lymphoma

  • LNP1265Phase 21 trial

    Regeneron · Hemophilia B

  • MAX-40279Phase 21 trial

    Maxinovel Pty., Ltd. · Acute Myeloid Leukemia

  • MBS303Phase 21 trial

    Beijing Mabworks Biotech Co., Ltd. · Non-Hodgkin's Lymphoma

  • MDSY-1240Phase 21 trial

    Medsyn Biopharma, LLC · Triple-Negative Breast Cancer (TNBC), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic

  • MDX2003Phase 21 trial

    ModeX Therapeutics, An OPKO Health Company · Lymphoma, Waldenström Macroglobulinemia (WM), DLBCL - Diffuse Large B Cell Lymphoma

  • ME-401Phase 21 trial

    Kyowa Kirin Co., Ltd. · Indolent B-cell Non-Hodgkin's Lymphoma

  • MEN1703SEL24, Dapolsertib hydrochloridePhase 21 trial

    Ryvu Therapeutics SA · Non-Hodgkin Lymphoma, B-cell

  • MS-553Phase 21 trial

    MingSight Pharmaceuticals, Inc · CLL (Chronic Lymphocytic Leukemia), SLL (Small Lymphocytic Lymphoma)

  • NVG-2089Phase 21 trial

    Nuvig Therapeutics, Inc. · Immune Thrombocytopenia (ITP)

  • OriCAR-017Phase 21 trial

    OriCell Therapeutics Co., Ltd. · Relapsed and/or Refractory Multiple Myeloma

  • OSE-279Phase 21 trial

    OSE Immunotherapeutics · Solid Advanced Tumor, Lymphoma, NSCLC (Non-small Cell Lung Cancer)

  • PBSS1113Phase 21 trial

    Chaser Therapeutics, Inc. · Acute Myeloid Leukemia (AML), MDS (Myelodysplastic Syndrome)

  • PegenzileukinSAR444245Phase 21 trial

    Sanofi · Plasma Cell Myeloma Refractory

  • PN20Phase 21 trial

    Chongqing Peg-Bio Biopharm Co., Ltd. · Thrombocytopenia Associated With Chronic Liver Disease

  • REC-1245Phase 21 trial

    Recursion Pharmaceuticals Inc. · Unresectable, Locally Advanced, Metastatic Cancers

  • REGN17372Phase 21 trial

    Regeneron · Relapsed Refractory Multiple Myeloma (RRMM)

  • REGN7945Phase 21 trial

    Regeneron · Relapsed/Refractory Multiple Myeloma

  • REGN7999Phase 21 trial

    Regeneron · Non-Transfusion Dependent Beta-Thalassemia (NTDT)

  • REGN9220Phase 21 trial

    Regeneron · Diffuse Large B-Cell Lymphoma (DLBCL)

  • REGV131Phase 21 trial

    Regeneron · Hemophilia B

  • Relmacabtagene AutoleucelJWCAR029Phase 21 trial

    Shanghai Ming Ju Biotechnology Co., Ltd. · Lymphoma, Large B-Cell, Diffuse, Follicular Lymphoma Grade 3B, High-grade B-cell Lymphoma

  • S241656Phase 21 trial

    Servier · Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Acute Myeloid Leukemia

  • S243249Phase 21 trial

    Servier · Relapsed or Refractory Acute Leukemia, Relapsed or Refractory Acute Myeloid Leukemia

  • sabatolimabMBG453Phase 21 trial

    Novartis · Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

  • SAL-0951SAL-0951 groupPhase 21 trial

    Shenzhen Salubris Pharmaceuticals Co., Ltd. · Anemia

  • SAR439459Phase 21 trial

    Sanofi · Plasma Cell Myeloma Refractory

  • SG2918Phase 21 trial

    Hangzhou Sumgen Biotech Co., Ltd. · Relapsed/Refractory Multiple Myeloma

  • SKLB1028Phase 21 trial

    CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Newly Diagnosed Acute Myeloid Leukemia (AML)

  • SLN124Phase 21 trial

    Silence Therapeutics plc · Polycythemia Vera

  • SNH-119014Phase 21 trial

    ScinnoHub Pharmaceutical Co., Ltd. · Thalassemia

  • SP-420Phase 21 trial

    Pharmacosmos A/S · Beta Thalassemia Major Anemia, Myelodysplastic Syndrome

  • spartalizumabPDR001Phase 21 trial

    Novartis · Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

  • SPK-8011QQRO7878488Phase 21 trial

    Roche (Genentech) · Hemophilia A

  • SSS06Phase 21 trial

    Shenyang Sunshine Pharmaceutical Co., LTD. · Chemotherapy-induced Anemia, Non-myeloid Malignancies

  • STI-6129Phase 21 trial

    Zhejiang ACEA Pharmaceutical Co. Ltd. · Relapsed or Refractory Multiple Myeloma

  • STSA-1301Phase 21 trial

    Jiangsu BioJeTay Biotechnology Co., Ltd. · Primary Immune Thrombocytopenia (ITP)

  • TAK-007Phase 21 trial

    Takeda · Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

  • TBI-1501Phase 21 trial

    Takara Bio Inc. · Lymphoblastic Leukemia, Acute Adult

  • TBS-2025trovostobartPhase 21 trial

    TuHURA Biosciences, Inc. · Acute Myeloid Leukemia

  • TC011Phase 21 trial

    TICAROS Co., Ltd. · Relapsed Large B-cell Lymphoma, Refractory Large B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL)

  • TGD001Phase 21 trial

    TargED Biopharmaceuticals B.V. · Thrombotic Microangiopathies, ITP Immune-Mediated Thrombocytopenia

  • TGRX-814Phase 21 trial

    Shenzhen TargetRx Co., Ltd. · Hematologic Malignancy, Non Hodgkin Lymphoma, Acute Myeloid Leukemia

  • TL-895Phase 21 trial

    Telios Pharma, Inc. · Myelofibrosis, Primary Myelofibrosis, Post-PV MF

NewerPage 6 of 7Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.